The roles of tumor-derived exosomes in cancer pathogenesis
/in Exosome, International Publications /von 2011-11-30 / Clin. Dev. Immunol. 2011;2011:842849Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-11-26 / Vaccine 2012 Jun;30(29):4394-7Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-11-23 / Int. J. Oncol. 2012 Mar;40(3):764-72Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-11-16 / Int. J. Oncol. 2012 Mar;40(3):840-50Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2011-11-16 / Cancer Immunol. Immunother. 2012 Jun;61(6):865-79Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo
/in International Publications, Newcastle Disease Virus, NSCLC /von 2011-11-15 / Cancer Lett. 2012 Apr;317(1):56-64Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2011-11-07 / World Neurosurg 2012 May-Jun;77(5-6):736-44Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients
/in Dendritic Cells, International Publications /von 2011-11-02 / J. Immunol. 2011 Dec;187(11):6130-42Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2011-11-01 / Anticancer Res. 2011 Nov;31(11):3995-4005
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution